Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

635 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study is proposed to investigate the pattern of dyslipidemia and of lipid treatment practices in patients in India experiencing their first acute cardiovascular event and the extent of residual dyslipidemia after 12 weeks of treatment with statins. Dyslipidemia definitions are per the National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Statins and Risk of Myocardial Infarction in Real Life in France

NCT00679575

Myocardial Infarction

COMPLETED

An Observational Study of Statin Treatment Induced HDL Changes

NCT01551784

Cardiovascular Disease

COMPLETED

Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus

NCT00217061

Diabetes Mellitus Dyslipidemia Hypercholesterolemia +1 more

COMPLETED PHASE3

Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients

NCT00128024

Myocardial Infarction

COMPLETED PHASE4

Effects of Intensive Statin Treatment on Left Ventricular Function

NCT01936103

Acute Anterior Myocardial Infarction

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidemias Hypercholesterolemia Hypertriglyceridemia High LDL-C Low HDL-C

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

Participants admitted to participating tertiary cardiac care centers who experienced a first coronary event.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently admitted with a confirmed diagnosis of first acute coronary event (STEMI/NSTEMI/Unstable Angina)
* Access to medical records covering the entire study period, and availability of data required for the study
* Potential to collect blood sample within 24 hours of onset for symptoms
* Considered for initiation/maintenance/modification of statin therapy before discharge from hospital
* Willing to comply with the study requirements

Exclusion Criteria

* Participating in a clinical trial or any type of other clinical study involving therapeutic intervention or otherwise failing to consent to interview
* Known inherited disorder of lipoprotein metabolism
* History of hypothyroidism, nephrotic syndrome, chronic alcoholism, Cushing syndrome

Minimum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No